M ost data concerning prognosis after transient ischemic attacks (TIAs) have come from hospital-based cohort studies or treatment trials. When applying the results of such studies in clinical practice, one needs to take into account several sources of bias: patients who were not referred to a hospital were excluded; many studies were based on retrospective reviews of case notes, making it difficult to apply strict diagnostic criteria uniformly; potentially hazardous treatments were sometimes used, which may have distorted the apparent prognosis (e.g., carotid surgery causes early death and strokes); and most investigators did not use life table analysis, which, given the different durations of follow-up, make comparisons between studies almost impossible. 1 There has been only one previous community-based study with enough patients to precisely estimate prognosis after TIAs. 2 We tried to identify in a defined population all patients presenting to a doctor with TIAs (whether referred to a hospital or not) and studied the prog-nosis of these patients. We describe the basic clinical characteristics of our TLA patients and the treatment that they received during follow-up. We describe their prognosis in terms of survival, risk of stroke, and risk of myocardial infarction.
Subjects and Methods
All patients entered into this follow-up study were identified prospectively by the Oxfordshire Community Stroke Project (OCSP), which has been described in detail elsewhere.
3 - 4 Here, we limit our description of the OCSP to only those details most relevant to this study of TLA prognosis. In the study population of approximately 105,000 persons, 184 incident cases of TLA occurred between November 1981 and October 1986. The study population included all persons permanently registered with 50 collaborating general practitioners (GPs) working in 10 group practices scattered throughout urban and rural Oxfordshire. We employed a variety of methods, which have been described elsewhere, 3 to ensure that we registered all new cases of TIA presenting to any of the collaborating GPs.
Each patient notified to the OCSP was assessed by the study neurologist as soon as possible after the notification event. If the patient fulfilled our criteria as an incident case of TLA, 4 he was followed up 1, 6, and 12 months and then annually after the date of notification. Follow-up was performed by a research nurse in most cases. Forty-four patients (24%) were also entered into the UK-TIA aspirin trial, 5 and they were seen by a neurologist every 4 months. At each follow-up visit the patient was questioned carefully about symptoms of stroke and myocardial infarction. If such symptoms were noted, the patient was reassessed by the study neurologist.
Regular follow-up ceased in November 1986, when one of us personally reexamined all but two of the 154 surviving patients; these two patients were contacted by telephone. A second electrocardiogram (ECG) was obtained for those reexamined and was available in the medical records of some of those who had died before November 1986.
During November 1988 one of us completed the follow-up by contacting the surviving patients again, either in person or by telephone, and questioning them about any new symptoms that had occurred since their entry into the study, specifically to detect strokes or myocardial infarction. A further ECG was not performed routinely at this final follow-up. Details of any treatment the patients had received during follow-up were recorded. Hospital and GP notes were scrutinized to detect any events that the patients themselves might have forgotten. If a patient had died, a judgement was made about the cause of death based on autopsy (if available) and medical records. We did not rely solely on information from death certificates to ascertain the cause of death since such information is known to be inaccurate. 6 We were unable to contact one patient at the final follow-up; we had followed this patient for almost 5 years, until he emigrated in 1987.
A TIA was defined as an acute loss of focal cerebral or ocular function with symptoms lasting <24 hours and which after adequate investigation was presumed to be due to embolic or thrombotic vascular disease. 7 Our definition of an incident case of TLA was rather complex and has been discussed in detail elsewhere. 4 From the point of view of this paper, the most important part of the definition is that it excluded any patient who suffered a stroke before notification to the OCSP, whether the stroke occurred before the TIA or after the TIA but before notification. Inclusion of such cases would have inevitably biased the cases toward those with a poor prognosis. We excluded patients who had a TIA diagnosed before November 1, 1981. Stroke was diagnosed according to a standard clinical definition. 3 Pathologic types of stroke (i.e., definite cerebral infarction, primary intracerebral hemorrhage) were diagnosed according to criteria described previously. 8 A stroke death was one in which either the symptoms or signs suggested that the patient died because of the direct neurologic sequelae of a stroke (e.g., transtentorial herniation or acute hydrocephalus), usually <.\ week after a stroke, or one in which the patient died as a result of complications of immobility (such as pulmonary embolism or pneumonia) caused by a stroke. A myocardial infarction was diagnosed when at least two of the following criteria were fulfilled: 1) the patient had a typical history of anterior chest pain, 2) the patient had a >50% rise in the concentrations of cardiac enzymes, and 3) the patient developed pathologic Q waves on a 12-lead ECG. Cardiac deaths included those following definite myocardial infarction but also included sudden deaths, those resulting from severe congestive heart failure and, in one case, autopsy-proven pericardial constriction.
Follow-up data are presented as Kaplan-Meier survival curves constructed using the methods described by Peto et al. 9 The day of notification to the OCSP (i.e., the first day that the patient was under observation and therefore at risk of suffering an event) was taken as day 0 of follow-up. The day of the first-ever or most recent TIA was not used since those patients who had suffered a stroke after a TIA but before notification to the OCSP had been excluded. Because we had access to age/sex-specific mortality rates for Oxfordshire 10 and stroke incidence 2 for our study population, we were able to calculate the number of deaths and strokes (but not myocardial infarctions) expected in 184 age-and sex-matched patients from the same population who were presumed not to have suffered a TIA. Assuming a Poisson distribution, we calculated the one-tailed probability that the number of events observed differed from the number expected by chance alone using the FORTRAN program PERSON-YEARS. 11 Approximate 95% confidence intervals (CIs) for the risk ratios (i.e., observed-;-expected) were taken from Poisson tables.
Results
We followed the 184 TLA patients (mean age 69.4 years; 103 [56%] men and 81 [44%] women) for a mean of 3.7 years (range 2 days to 7 years). The median intervals from the incident TIA to notification to the OCSP and from notification to assessment by the study neurologist were both 3 days; the median interval from the patient's first-ever TIA (whether reported to a doctor or not) to notification was 6 days. At the initial assessment, 62 TIA patients (34%) were receiving antihypertensive drugs. During follow-up two such patients (3%) had their antihypertensive treatment stopped, but at the final follow-up or death 81 (44% of all TIA patients) were receiving antihypertensive drugs. One hundred five patients (57%) received regular aspirin and 15 (8%) received warfarin at some time during follow-up. Forty-five patients (24%) underwent carotid angiography (with no cerebral complications), but only six patients (3%) had carotid endarterectomy (two others were randomized to the "no surgery" group of the European Carotid Surgery Trial). One of these six patients undergoing endarterectomy had a stroke immediately after surgery.
Forty-nine patients (22 men and 27 women) died during follow-up; the causes of death are shown in Table 1 . The Kaplan-Meier survival curve (Figure 1) shows that the probability of dying was 31.3% (95% CI 23.3%-39.3%) by 5 years, an annual risk of death of approximately 6.3% (95% CI 4.7%-7.9%). shows the observed and expected number of deaths for the patients by sex and age groups. The number of deaths observed was significantly (p=0.02) greater than that expected. Forty-five patients (22 men and 23 women) had a first-ever stroke during follow-up. Twenty-nine had definite cerebral infarcts on computed tomography (CT) or at autopsy, while only one (a patient taking aspirin) had a definite primary intracerebral hemorrhage. Fifteen patients had neither an autopsy nor CT. Twenty-seven strokes (60%) affected the same vascular territory as the incident TLA. Sixteen (36%) were minor strokes that caused no long-term disability. The Kaplan-Meier survival curve showing the risk of fatal or nonfatal stroke following notification to the OCSP with a TIA (censoring patients dying of other causes) is shown in Figure 2 . The probability of stroke during the first 5 years was 29.3% (95% CI 21.3%-37.3%), with a mean annual risk of approximately 5.9% (95% CI 4.3%-7.5%). However, the risk of stroke was 4.4% (95% CI 1.5%-7.3%) during the first month, 8.8% (95% CI 4.7%-12.9%) during the first 6 months, and 11.6% (95% CI 6.9%-16.3%) during the first 12 months after notification. Table 3 shows the observed and expected number of strokes for the patients by sex and age groups. Patients with a TIA have seven (95% CI 5.1-9.3) times the risk of stroke over the next 7 years than a person free of TIAs. The risk ratio during the first 12 months after notification was 13.4 (95% CI 8.2-20.7), considerably more than in subsequent years.
Seventeen patients had a definite myocardial infarction during follow-up. The risk of myocardial infarction was 12.1% (95% CI 5.8%-18.4%) during the first 5 years (Figure 3) TIA, transient ischemic attack; risk ratio, observed+expected; CI, confidence interval;/?, one-tailed probability not due to chance. death, a mean of 2.3 years later. In 35 (21%) of the 170 second ECGs, differences from the initial ECG were seen, but none showed definite evidence of a myocardial infarction that had not been evident clinically (i.e., no silent myocardial infarctions were found).
The risk of dying or suffering either a stroke or a myocardial infarction is illustrated in Figure 4 . The annual risk of suffering one of these important events following a TIA was approximately 8.4% (95% CI 6.8%-10.1%). 2 has published useful prognostic data; the others identified too few cases, had inadequate follow-ups, or did not use actuarial analysis of the survival data. If one studies young patients with TIAs, their overall survival (and perhaps their risk of stroke) will be lower than that of older patients. The average age of patients included in the hospitalbased studies varied from 49 17 to 63 18 years, while the average age of our patients was 69.4 years. The prevalence of associated diseases such as ischemic heart disease, hypertension, and diabetes mellitus (all of which seem likely to be important determinants of prognosis) has also varied considerably among cohorts of TIA patients and in particular may be affected by whether the patients are referred to a hospital.
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Although the study from the Mayo Clinic 2 has been by far the most satisfactory because it was community-based (and thus aimed to include most TIAs occurring in a defined population) and had many cases (n = 198) with long and complete followups, there were some important problems. First, cases were identified retrospectively from a diagnostic index. Diagnostic accuracy may be lower in this sort of study since diagnoses must be based on data recorded in the medical records, in which strict criteria for diagnosis may not have been applied systematically. The actual incidence rate for TIA in the population of Rochester, Minnesota, may be as much as 50% higher than that reported based on the medical record linkage system (J.P. Whisnant, personal communication). The extent to which this underestimation may have biased the estimate of prognosis is not known. Second, the early and most widely quoted papers from the Mayo Qinic study of prognosis 2 -19 included some patients who presented only after they had suffered a stroke, which inevitably biased the group toward those with an increased risk of stroke. Whisnant and Wiebers 20 have reanalyzed the original data to exclude such patients, which resulted in slightly more optimistic estimates of early prognosis. The Mayo Clinic study, in common with most other studies of prognosis, gave little information about the treatment that the patients received during follow-up.
Four large hospital-based studies 22 showed that survival following a TIA was significantly worse than that expected for patients free of TTAs in the general population. In the community-based study of Whisnant and Wiebers, 20 the probability of dying within 5 years was 37% (95% CI 30.4%-43.6%), compared with 31.3% (95% CI 23.3%-39.3%) in our study. These authors 20 have shown that patients with TIAs have a risk of dying during the first year 2.6 times that of unaffected individuals. Rather surprisingly, these authors found that during the first month there was a 10-fold increased risk of death although they did not give the causes of the early deaths or the CIs for these risk ratios. The risks of dying within 1 and 12 months after entry into the OCSP were not significantly greater (see Table 2 ) than expected for the general population, although given the fairly small numbers and the wide CIs we could not exclude increased risks of the order described by Whisnant and Wiebers. 20 Heyden and colleagues 24 identified 28 cases of definite TLA in a community and demonstrated that those with TIAs had an almost threefold increased risk of dying compared with people free of TIAs. Howard et al 23 showed that TLA patients with more than one vascular risk factor had a significantly increased mortality while those with no associated risk factors had no greater risk of dying than people of the same age in the general population. When comparing the results of different studies one must remember the fairly wide CIs surrounding the estimates of prognosis; apparent differences between studies may be due simply to sample variability rather than to true differences in prognosis.
Very few studies have expressed the risk of stroke following a TLA in the form of a life table or survival curve, which makes comparison with other studies difficult. The largest study (n=390) that produced survival curves was the prospective hospital-based study of Heyman and colleagues. 18 These authors showed that the risk of stroke was approximately 24% during the first 5 years, although risk of stroke within 1 month after entering the study was 7%. This very high early risk of stroke was largely due to complications of angiography and carotid surgery. The apparent prognosis would have been even worse had the authors not excluded from analysis those stroke patients who recovered completely within a few weeks. In the Mayo Clinic series 20 the risk of stroke during the first 5 years was 29% (95% CI 22.0%-36.0%), not different from that in our series. These authors found that the risk of stroke was 8% (95% CI 4.2%-11.8%) by 1 month, 10% (95% CI 6.7%-14.3%) by 6 months, and 13% (95% CI 8.1%-17.9%) during the first 12 months. These figures are very similar to ours, except that their risk of stroke during the first month was greater than ours (4.4%). It is not clear whether this difference was due to chance (note the wide 95% CIs), to methodologic differences, or to complications of aggressive treatment at the Mayo Clinic (as in the study of Heyman et al 18 ) . A difference in early prognosis could have resulted from differences in the interval from the incident TLA to entry into the follow-up study. The Mayo Clinic study was retrospective; the authors counted the first-ever TIA as the incident event and used its occurrence as day 0 of follow-up even though the patients were not strictly under observation from that moment. In our study, although the interval from the incident TLA to entry into the OCSP was short, the incident TIA was not necessarily the first-ever TLA and therefore our patients were entered into the follow-up study at a later stage in their disease than those in the Mayo Clinic study; this could account, at least in part, for the better early prognosis in our study. Our study probably reflects prognosis from the doctor's perspective while the Mayo Qinic study reflects prognosis from the patient's perspective. Unless one detects all cases of TLA (including those in persons who do not consult a doctor), using the first-ever TIA as the event from which one measures follow-up may bias the results.
Because Whisnant and colleagues carried out a parallel study of stroke incidence, 25 they were also able to calculate relative risk of stroke for persons with and without TIAs. The relative risk of stroke during the first 12 months was 16.5 times and that during the first 5 years was 7.3 times that in persons without TIA. These figures are very similar to ours (i.e., 13.4 and 7.0, respectively). All of these data point to a somewhat higher risk of stroke during the first 12 months after a TIA than in subsequent years even if iatrogenic strokes are ignored.
No previous community-based studies have reported the risk of myocardial infarction following TIAs, although Heyman et al 18 demonstrated a risk of sudden death or myocardial infarction of 21% within 5 years after a TLA in their hospital-referred cohort. Interestingly, we detected no silent myocardial infarctions in our patients even though many had coexistent cardiac disease.
In conclusion, it appears that the prognosis following a TIA in Oxfordshire was similar to, or even slightly better than, those suggested in previous studies even though our patients were on average older. Patients with TIAs appear to have a slightly increased risk of dying, and they certainly have a much increased risk of stroke over the next few years. The risk of stroke is greater immediately after the TIA, which has important implications for clinical practice and for planning trials of treatments to prevent stroke after TIAs. For a patient to get maximum benefit from such a treatment, it must be started as early as possible. Many of the subsequent strokes in our study were nondisabling, and 40% occurred in a vascular territory different from that of the incident TIA; these factors should be borne in mind when considering potentially hazardous procedures such as carotid endarterectomy. The next stage in research on TIA prognosis must be to determine those variables that put a patient at much higher than average risk of stroke since such patients are more likely to benefit from potentially hazardous treatments.
